Safety of abacavir therapy after temporary interruptions in patients without hypersensitivity reactions to the drug

被引：3

作者：

Berenguer, J

Padilla, B

Estrada, V

Martín, C

Domingo, P

Kindelán, JM

Ruiz-Guiardin, JM

机构：

[1] Hosp Gen Gregorio Maranon, Infect Dis Serv, E-28007 Madrid, Spain

[2] Hosp Clin San Carlos, Madrid, Spain

[3] Complejo Hosp Caceres, Caceres, Spain

[4] Hosp Santa Cruz & San Pablo, E-08025 Barcelona, Spain

[5] Hosp Reina Sofia, Cordoba, Spain

[6] Hosp La Princesa, Madrid, Spain

来源：

AIDS | 2002年 / 16卷 / 09期

关键词：

D O I：

10.1097/00002030-200206140-00018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1299 / 1301

页数：3

共 5 条

[1] Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA [J].

Clumeck, N ;

Goebel, F ;

Rozenbaum, W ;

Gerstoft, J ;

Staszewski, S ;

Montaner, J ;

Johnson, M ;

Gazzard, B ;

Stone, C ;

Athisegaran, R ;

Moore, S .

AIDS, 2001, 15 (12) :1517-1526

[2] Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity [J].

Frissen, PHJ ;

de Vries, J ;

Weigel, HM ;

Brinkman, K .

AIDS, 2001, 15 (02) :289-289

[3]

HETHERINGTON S, 2000, 7 C RETR OPP INF SAN

[4] The abacavir hypersensitivity reaction and interruptions in therapy [J].

Loeliger, AE ;

Steel, H ;

McGuirk, S ;

Powell, WS ;

Hetherington, SV .

AIDS, 2001, 15 (10) :1325-1325

[5] Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial [J].

Staszewski, S ;

Keiser, P ;

Montaner, J ;

Raffi, F ;

Gathe, J ;

Brotas, V ;

Hicks, C ;

Hammer, SM ;

Cooper, D ;

Johnson, M ;

Tortell, S ;

Cutrell, A ;

Thorborn, D ;

Isaacs, R ;

Hetherington, S ;

Steel, H ;

Spreen, W .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (09) :1155-1163

← 1 →